Parenteral Nutrition Support for Patients With Pancreatic Cancer
Phase 2
Completed
- Conditions
- Cancer CachexiaPancreatic Cancer
- Interventions
- Dietary Supplement: parenteral nutrition
- Registration Number
- NCT00919659
- Lead Sponsor
- CONKO-Studiengruppe
- Brief Summary
The purpose of this study is to determine whether the additional nutrition support is improving the nutritional status of patients suffering cancer caxechia or not.
- Detailed Description
To examine the impact of additional parenteral nutrition (APN) we prospective evaluated 32 pts suffering APC and progressive cachexia. This assay is based on a bioelectrical impedance analysis (BIA) as a proven tool for nutritional investigation in patients with chronic disease. Phase angle, determined by BIA, has been found to be a prognostic indicator in several chronic and malignant conditions, such as HIV, liver cirrhosis, chronic obstructive pulmonary disease lung cancer and pancreatic cancer.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
- histological proved pancreatic cancer
- progressive cancer cachexia
- refractive to enteral supplementation
- informed consent
Exclusion Criteria
- prefinal status
- septic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description parenteral nutrition parenteral nutrition 25kcal/kg/bw /day via parenteral support
- Primary Outcome Measures
Name Time Method nutritional status presented by phase angle 12 weeks
- Secondary Outcome Measures
Name Time Method quantity of port infections, quantity of oedema, quantity of diarrhea 12 weeks
Trial Locations
- Locations (1)
Universitätsmedizin Berlin - Charité
🇩🇪Berlin, Germany